Serum amyloid A is elevated in the serum of lung cancer patients with poor prognosis
Authors:
Open Access
- 25 May 2010
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 102 (12) , 1731-1735
Abstract
Background: Methods: Results: Conclusion:Keywords
This publication has 27 references indexed in Scilit:
- Serum amyloid ACancer, 2009
- Two-protein signature of novel serological markers apolipoprotein-A2 and serum amyloid alpha predicts prognosis in patients with metastatic renal cell cancer and improves the currently used prognostic survival modelsAnnals of Oncology, 2009
- MALDI Profiling of Human Lung Cancer SubtypesPLOS ONE, 2009
- Elevated Biomarkers of Inflammation Are Associated With Reduced Survival Among Breast Cancer PatientsJournal of Clinical Oncology, 2009
- Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancerBritish Journal of Cancer, 2009
- Dynamic Proteomics of Individual Cancer Cells in Response to a DrugScience, 2008
- Proteinchip2008
- Contribution of oncoproteomics to cancer biomarker discoveryMolecular Cancer, 2007
- Rapid recycling of cholesterol: The joint biologic role of C-reactive protein and serum amyloid AMedical Hypotheses, 2006
- Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patientsLaboratory Investigation, 2004